E Ho Selected Research

E Ho Research Topics

Disease

2	COVID-19 12/2022 - 01/2021
2	Prostatic Neoplasms (Prostate Cancer) 12/2014 - 07/2013
2	Liver Diseases (Liver Disease) 09/2013 - 03/2012
2	Inflammation (Inflammations) 03/2012 - 03/2011
2	Fibrosis (Cirrhosis) 03/2012 - 03/2011
2	Malaria 04/2003 - 10/2002
2	Hyperglycemia 02/2001 - 02/2000
1	Obesity 01/2022
1	Stroke (Strokes) 01/2019
1	Disease Progression 12/2014
1	Colonic Neoplasms (Colon Cancer) 10/2014
1	Renal Artery Obstruction (Renal Artery Stenosis) 05/2014
1	Hypertension (High Blood Pressure) 05/2014
1	Hemophilia B (Haemophilia B) 09/2013
1	Hemorrhage 09/2013
1	Hepatocellular Carcinoma (Hepatoma) 03/2012
1	Chronic Hepatitis C 03/2012
1	Hypersensitivity (Allergy) 10/2009
1	Melanoma (Melanoma, Malignant) 10/2009
1	Neoplasms (Cancer) 10/2009
1	Drug-Related Side Effects and Adverse Reactions 11/2001
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 11/2001
1	Binge Drinking 11/2001
1	Pain (Aches) 05/2001
1	Critical Illness (Critically Ill) 12/2000
1	Multiple Sclerosis 06/2000
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 06/2000
1	Autoimmune Diseases (Autoimmune Disease) 06/2000
1	Giardiasis 05/2000
1	Infections 05/2000
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2000

Drug/Important Bio-Agent (IBA)

2	DNA (Deoxyribonucleic Acid)IBA 09/2013 - 03/2011
2	Streptozocin (Streptozotocin)FDA Link 02/2001 - 02/2000
2	AlloxanIBA 02/2001 - 02/2000
1	AerosolsIBA 12/2022
1	Biological ProductsIBA 01/2022
1	SugarsIBA 01/2021
1	Biocompatible Materials (Biomaterials)IBA 01/2019
1	Androgen Receptors (Androgen Receptor)IBA 12/2014
1	isothiocyanic acidIBA 12/2014
1	sulforaphaneIBA 12/2014
1	Histone MethyltransferasesIBA 12/2014
1	Histones (Histone)IBA 10/2014
1	AcidsIBA 10/2014
1	Growth Hormone (Somatotropin)IBA 05/2014
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 09/2013
1	Amino Acids FDA Link 09/2013
1	Polysaccharides (Glycans)IBA 09/2013
1	AndrogensIBA 07/2013
1	telaprevirIBA 03/2012
1	RNA (Ribonucleic Acid)IBA 03/2012
1	Protease Inhibitors (Protease Inhibitor)IBA 03/2012
1	InterferonsIBA 03/2012
1	Antiviral Agents (Antivirals)IBA 03/2012
1	Viral ProteinsIBA 03/2012
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 03/2012
1	Interferon-alpha (Interferon Alfa)IBA 03/2011
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2009
1	Dactinomycin (Actinomycin)FDA LinkGeneric 10/2009
1	Neoplasm Antigens (Tumor Antigens)IBA 10/2009
1	Interleukin-4 (Interleukin 4)IBA 10/2009
1	hemozoinIBA 04/2003
1	Proteins (Proteins, Gene)FDA Link 10/2002
1	Illicit Drugs (Recreational Drugs)IBA 11/2001
1	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 11/2001
1	Insulin (Novolin)FDA Link 02/2001
1	ZincIBA 02/2001
1	Atracurium (Tracrium)FDA Link 12/2000
1	BX 471IBA 06/2000
1	Chemokine ReceptorsIBA 06/2000
1	CC ChemokinesIBA 06/2000
1	Peptides (Polypeptides)IBA 06/2000
1	Pharmaceutical PreparationsIBA 05/2000
1	Metronidazole (Metric)FDA LinkGeneric 05/2000
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2000

Therapy/Procedure

3	Therapeutics 07/2013 - 03/2011
1	Tracheostomy 12/2022
1	Intravenous Administration 09/2013
1	Subcutaneous Injections 09/2013
1	Ambulatory Care (Outpatient Care) 07/2013
1	Aftercare (After-Treatment) 03/2012
1	Immunotherapy 10/2009
1	Analgesia 05/2001
1	Liver Transplantation 12/2000